dna-hiv-pt123
Vaccineexperimental
Clinical trial activity
10 trials · 26 clinical orgs · 0 marketing orgs
Phase 1
9
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2012 (NCT01799954)
Timeline
Indications
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dna-hiv-pt123
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04844775 | Phase 1 | Jun 30, 2021 | CHU Henri Mondor, European Commission, EuroVacc Foundation, Government of France, Government of Switzerland, Imperial College London, Medical Research Council, University of London |
| NCT04066881 | Phase 2 | Jan 31, 2020 | CONRAD, EuroVacc Foundation, Gilead Sciences, Government of Mozambique, Imperial College London, International AIDS Vaccine Initiative, Karolinska Institute, Ludwig Maximilians University, Medical Research Council, Medical Research Council, South Africa, Medical Research Council-UVRI Uganda Research Unit on AIDS, Muhimbili University, National Institute for Medical Research, Tanzania, University of Lausanne, University of London |
| NCT03391375 | Phase 1 | Mar 15, 2017 | EuroVacc Foundation, International AIDS Vaccine Initiative, Medical Research Council-UVRI Uganda Research Unit on AIDS, University of Lausanne |
| NCT02915016 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2016 | Centre for the AIDS Programme of Research in South Africa, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT02997969 | Phase 1 | May 1, 2016 | HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID), Novartis, University of Lausanne, University of North Carolina at Chapel Hill |
| NCT02207920 | Phase 1 | Jul 1, 2014 | National Institute of Allergy and Infectious Diseases (NIAID), University of Rochester |
| NCT01964937 | Phase 1 | Oct 15, 2013 | EuroVacc Foundation, National Institute of Allergy and Infectious Diseases (NIAID), University of Lausanne, University of Rochester |
| NCT01927835 | Phase 1 | Aug 20, 2013 | Columbia University, EuroVacc Foundation, HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID), University of Lausanne |
| NCT01783977 | Phase 1 | Apr 1, 2013 | National Institute of Allergy and Infectious Diseases (NIAID), University of Lausanne |
| NCT01799954 | Phase 1 | Aug 1, 2012 | HIV Vaccine Trials Network, University of Lausanne |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (26)
26 organizations
Page 1 / 2